Unknown

Dataset Information

Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort.


ABSTRACT:

Introduction

Few studies have examined the effects of amyloid and apolipoprotein E (APOE) genotype on cognition among middle-aged individuals.

Methods

We included 464 cognitively normal, test-naïve, participants with Pittsburgh compound B positron emission tomography amyloid imaging, mean age of 62.7 (range, 51-71 years), enrolled in the Mayo Clinic Study of Aging. Participants completed multiple cognitive assessments, including a standard neuropsychological battery and the CogState computerized battery, over 30 months of follow-up. Linear mixed models were used to examine the effects of amyloid and APOE genotype on baseline cognition and cognitive decline.

Results

Elevated amyloid was not associated with tests of episodic memory but did predict declines on tests of e

SUBMITTER: Mielke MM 

PROVIDER: S-EPMC4850495 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature